Pricing Log in Create free account
Friday 6 November 2026 Export COO’s income statement to Excel — free account

The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.

Revenue
+0.56%
EPS
+357.1%
Free cash flow
+66.0%
Total debt
+2.66%

Quarter to July 2026, against a year earlier

62.61 0.90 −1.42%
Market cap
$12.1B
P/E
21.7×
Fwd P/E
17.5×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

The Cooper Companies, Inc. 10-Q filed Aug 28, 2025

Fiscal Q3 2025 · Period ended Jul 31, 2025 · Filed · accepted 4:18 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed May 30, 2025: 6 added · 3 removed · 18 modified; 11 with only figures updated

  1. Modified · CooperVision Net Sales by Category

    In the three and sixnine months ended April 30July 31, 2025, the growth experienced across all categories was partially offsetpositively impacted by unfavorablefavorable foreign exchange rate fluctuations of approximately $7.726.8 million and $22.44.4 million, respectively.